Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis vaccines.

Douglas B Young1, Graham R Stewart

  • 1Centre for Molecular Microbiology and Infection, Faculty of Medicine, Imperial College of Science, Technology and Medicine, South Kensington, London, UK.

British Medical Bulletin
|August 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First confirmation of Mycobacterium tuberculosis complex from medieval Ireland by aDNA analysis - palaeopathological and microbial findings.

Tuberculosis (Edinburgh, Scotland)·2025
Same author

Author Correction: Control of replication and gene expression by ADP-ribosylation of DNA in Mycobacterium tuberculosis.

The EMBO journal·2025
Same author

Control of replication and gene expression by ADP-ribosylation of DNA in Mycobacterium tuberculosis.

The EMBO journal·2025
Same author

Identification of gene targets that potentiate the action of rifampicin on <i>Mycobacterium bovis</i> BCG.

Microbiology (Reading, England)·2024
Same author

Corrigendum: Lack of methoxy-mycolates characterizes the geographically restricted lineage 7 of <i>Mycobacterium tuberculosis</i> complex.

Microbial genomics·2024
Same author

Bioarchaeological investigation of individuals with suspected multibacillary leprosy from the mediaeval <i>leprosarium</i> of St Mary Magdalen, Winchester, Hampshire, UK.

Journal of medical microbiology·2024
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Improved vaccines are crucial due to rising tuberculosis (TB) cases linked to HIV. Research focuses on preventing infection, reactivation, and relapse, utilizing new vaccine candidates and ongoing immune response studies.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Rising incidence of tuberculosis (TB) disease in individuals with human immunodeficiency virus (HIV) infection underscores the importance of immune response.
  • Susceptibility to TB is closely linked to immune status, necessitating advanced vaccine development.

Purpose of the Study:

  • To explore novel vaccine strategies targeting naive individuals, latent TB infection reactivation, and relapse prevention in TB patients.
  • To review advancements in mycobacterial genetics for developing live attenuated and subunit vaccine candidates.

Main Methods:

  • Screening of various live attenuated and subunit vaccine candidates in experimental infection models.
  • Evaluation of immunogenicity of selected candidate vaccines in clinical trials.

Related Experiment Videos

Main Results:

  • Development of diverse vaccine candidates through advances in mycobacterial molecular genetics.
  • Screening of candidates in experimental models indicates potential for further development.

Conclusions:

  • Clinical trial evaluation of vaccine immunogenicity is essential.
  • Continued fundamental research on immune responses to mycobacterial infection and persistence is critical for effective vaccine design.